In a large cohort of 14,287 CRC cases from the Caris Life Sciences database, Arai et al. reported that high CD47 tumors were enriched in CMS1 and CMS4, both associated with immune activation and unfavorable outcomes [93]. The gene discussed is CD47; the disease is colorectal carcinoma.